Ashish Dugar, PhD, MBA
Executive in Residence
Dr. Ashish “Ash” Dugar is a business leader with experience in clinical development & medical affairs, market access & health economics, commercial & business development, and new product assessment. He has a deep understanding of the global healthcare environment, market trends, and drug development. Ash is the Senior Vice President, Global Head of Medical Affairs at Dyne Therapeutics. Previously Ash was Vice-President, Global Medical Affairs at Sarepta Therapeutics, a $12B+ company leading the field in precision genetic medicine with one of the world’s largest gene therapy pipelines. Prior to his role at Sarepta, Ash was an Officer & Vice-President of Commercial Development at Intracellular Therapies where he was responsible for developing commercial and market access strategies. Before that role, he was the Global Head, Clinical Development Science & Innovation at Roche in NYC, where his group’s remit was to evaluate external opportunities and subsequently plan and execute the non-clinical and early-stage clinical development of those externally sourced assets. Additionally, Ash spent time as VP, Biosimilars for Cardinal Health (CAH) Specialty Solutions. And before joining CAH, Ash was Pfizer’s Vice President, Global Head, Medicines Development Group for Biosimilars, where his team advanced Oncology and Autoimmune agents in the clinic. Also, at Pfizer, Ash led technical and commercial teams that evaluated external licensing and acquisition opportunities.